1. CRISPR/Cas9 knockout of MTA1 enhanced RANKL‐induced osteoclastogenesis in RAW264.7 cells partly via increasing ROS activities. Issue 5 (14th February 2023) Authors: Feng, Mingzhe; Liu, Lin; Qu, Zechao; Zhang, Bo; Wang, Yanjun; Yan, Liang; Kong, Lingbo Journal: Journal of cellular and molecular medicine Issue: Volume 27:Issue 5(2023) Page Start: 701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Urolithin B suppresses osteoclastogenesis via inhibiting RANKL‐induced signalling pathways and attenuating ROS activities. Issue 16 (3rd July 2022) Authors: Qu, Zechao; An, Hao; Feng, Mingzhe; Huang, Wangli; Wang, Dong; Zhang, Zhen; Yan, Liang Journal: Journal of cellular and molecular medicine Issue: Volume 26:Issue 16(2022) Page Start: 4428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗